Skip to main content
SpringerLink
Log in

Long-Term Outcome of Revascularization Surgery for Moyamoya Disease in Korea

  • Chapter
  • First Online:
Moyamoya Disease: Current Knowledge and Future Perspectives

  • 439 Accesses

Abstract

Moyamoya disease (MMD) is a rare chronic cerebral ischemic disease with unknown etiology that shows characteristic angiographic features of intracranial collateral vessels. Revascularization surgery (RVS) is a well-known method for the augmentation of cerebral perfusion in MMD. Based on the surgical procedures, RVS for MMD is classified as direct, indirect, and combined. For RVS, there are many aspects to consider, such as age (pediatric vs. adult), surgical indication, and selection of surgical procedures (indirect vs. direct vs. combined). Along with these aspects, we analyzed and described the outcome of RVS in both pediatric and adult MMD in Korea with a review of pertinent literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lee SU, Kim T, Kwon OK, Bang JS, Ban SP, Byoun HS, et al. Trends in the incidence and treatment of cerebrovascular diseases in Korea: part II. Cerebral infarction, cerebral arterial stenosis, and Moyamoya disease. J Korean Neurosurg Soc. 2020;63(1):69–79.

    Article  PubMed  Google Scholar 

  2. Oh CW. The overall trends of neurosurgical diseases in Korea: analysis of the incidence of diseases and treatment modalities using NHIS data from 2010 to 2016. Health Insurance Review & Assessment Service; 2017.

    Google Scholar 

  3. Spetzler RF, Roski RA, Kopaniky DR. Alternative superficial temporal artery to middle cerebral artery revascularization procedure. Neurosurgery. 1980;7(5):484–7.

    Article  CAS  PubMed  Google Scholar 

  4. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–99.

    Article  CAS  PubMed  Google Scholar 

  5. Matsushima Y, Fukai N, Tanaka K, Tsuruoka S, Inaba Y, Aoyagi M, et al. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg Neurol. 1981;15(4):313–20.

    Article  CAS  PubMed  Google Scholar 

  6. Matsushima Y, Inaba Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Childs Brain. 1984;11(3):155–70.

    CAS  PubMed  Google Scholar 

  7. Karasawa J, Kikuchi H, Furuse S, Sakaki T. Yoshida Y. a surgical treatment of “moyamoya” disease “encephalo-myo synangiosis”. Neurol Med Chir. 1977;17(1 Pt 1):29–37.

    Article  CAS  Google Scholar 

  8. Kinugasa K, Mandai S, Kamata I, Sugiu K, Ohmoto T. Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms. Neurosurgery. 1993;32(4):527–31.

    Article  CAS  PubMed  Google Scholar 

  9. Kim SK, Wang KC, Kim IO, Lee DS, Cho BK. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery. 2002;50(1):88–96.

    PubMed  Google Scholar 

  10. Houkin K, Kuroda S, Ishikawa T, Abe H. Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease? Acta Neurochir. 2000;142(3):269–76.

    Article  CAS  PubMed  Google Scholar 

  11. Matsushima T, Inoue T, Katsuta T, Natori Y, Suzuki S, Ikezaki K, et al. An indirect revascularization method in the surgical treatment of moyamoya disease--various kinds of indirect procedures and a multiple combined indirect procedure. Neurol Med Chir. 1998;38(Suppl):297–302.

    Article  Google Scholar 

  12. Saito N, Imai H. Insights on the revascularization mechanism for treatment of Moyamoya disease based on the histopathologic concept of angiogenesis and arteriogenesis. World Neurosurg. 2011;75(2):204–5.

    Article  PubMed  Google Scholar 

  13. Nakashima H, Meguro T, Kawada S, Hirotsune N, Ohmoto T. Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg. 1997;99(Suppl 2):S156–61.

    Article  PubMed  Google Scholar 

  14. Shim KW, Park EK, Kim JS, Kim DS. Cognitive outcome of pediatric Moyamoya disease. J Korean Neurosurg Soc. 2015;57(6):440–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Pandey P, Steinberg GK. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. J Neurosurg. 2011;115(2):328–36.

    Article  PubMed  Google Scholar 

  16. Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Yamazoe N, Akiyama Y. Pitfalls in the surgical treatment of moyamoya disease. Operative techniques for refractory cases. J Neurosurg. 1988;68(4):537–43.

    Article  CAS  PubMed  Google Scholar 

  17. Matsushima Y. Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease. Pediatr Neurosci. 1985;12(6):326–7.

    Article  PubMed  Google Scholar 

  18. Cahan LD. Failure of encephalo-duro-arterio-synangiosis procedure in moyamoya disease. Pediatr Neurosci. 1985;12(1):58–62.

    Article  PubMed  Google Scholar 

  19. Tenjin H, Ueda S, Multiple EDAS. (Encephalo-duro-arterio-synangiosis). Additional EDAS using the frontal branch of the superficial temporal artery (STA) and the occipital artery for pediatric moyamoya patients in whom EDAS using the parietal branch of STA was insufficient. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery. 1997;13(4):220–4.

    Article  CAS  Google Scholar 

  20. Kinugasa K, Mandai S, Tokunaga K, Kamata I, Sugiu K, Handa A, et al. Ribbon enchephalo-duro-arterio-myo-synangiosis for moyamoya disease. Surg Neurol. 1994;41(6):455–61.

    Article  CAS  PubMed  Google Scholar 

  21. Sainte-Rose C, Oliveira R, Puget S, Beni-Adani L, Boddaert N, Thorne J, et al. Multiple bur hole surgery for the treatment of moyamoya disease in children. J Neurosurg. 2006;105(6 Suppl):437–43.

    PubMed  Google Scholar 

  22. Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK. Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis (Basel, Switzerland). 2008;25(6):580–6.

    Article  Google Scholar 

  23. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007;67(3):273–82.

    Article  PubMed  Google Scholar 

  24. Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, et al. Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke. 2014;45(10):3025–31.

    Article  PubMed  Google Scholar 

  25. Uchino H, Kim JH, Fujima N, Kazumata K, Ito M, Nakayama N, et al. Synergistic interactions between direct and indirect bypasses in combined procedures: the significance of indirect bypasses in Moyamoya disease. Neurosurgery. 2017;80(2):201–9.

    Article  PubMed  Google Scholar 

  26. Fujimura M, Tominaga T. Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir. 2012;52(5):327–32.

    Article  Google Scholar 

  27. Kim JE, Jeon JS. An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues. Neurol Res. 2014;36(5):407–16.

    Article  PubMed  Google Scholar 

  28. Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, et al. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol. 2010;68(1):92–101.

    Article  PubMed  Google Scholar 

  29. Suzuki Y, Negoro M, Shibuya M, Yoshida J, Negoro T, Watanabe K. Surgical treatment for pediatric moyamoya disease: use of the superficial temporal artery for both areas supplied by the anterior and middle cerebral arteries. Neurosurgery. 1997;40(2):324–9. discussion 9–30

    Article  CAS  PubMed  Google Scholar 

  30. Matsushima Y, Aoyagi M, Masaoka H, Suzuki R, Ohno K. Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery. 1990;6(8):440–3.

    Article  CAS  Google Scholar 

  31. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100(2 Suppl Pediatrics):142–9.

    PubMed  Google Scholar 

  32. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery. 2004;54(4):840–4. discussion 4–6

    Article  PubMed  Google Scholar 

  33. Narisawa A, Fujimura M, Tominaga T. Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions. Clin Neurol Neurosurg. 2009;111(2):123–6.

    Article  PubMed  Google Scholar 

  34. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg. 2009;111(5):927–35.

    Article  PubMed  Google Scholar 

  35. Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan adult Moyamoya trial. Stroke. 2014;45(5):1415–21.

    Article  PubMed  Google Scholar 

  36. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005;36(10):2148–53.

    Article  PubMed  Google Scholar 

  37. Yamada M, Fujii K, Fukui M. [clinical features and outcomes in patients with asymptomatic moyamoya disease--from the results of nation-wide questionnaire survey]. No shinkei geka. Neurol Surg. 2005;33(4):337–42.

    Google Scholar 

  38. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38(5):1430–5.

    Article  PubMed  Google Scholar 

  39. Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, et al. The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg. 2015;122(1):82–9.

    Article  PubMed  Google Scholar 

  40. Kuroda S. Asymptomatic moyamoya disease: literature review and ongoing AMORE study. Neurol Med Chir. 2015;55(3):194–8.

    Article  Google Scholar 

  41. Lee SC, Jeon JS, Kim JE, Chung YS, Ahn JH, Cho WS, et al. Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir. 2014;156(1):103–11.

    Article  PubMed  Google Scholar 

  42. Hayashi K, Horie N, Izumo T, Nagata I. A nationwide survey on unilateral moyamoya disease in Japan. Clin Neurol Neurosurg. 2014;124:1–5.

    Article  PubMed  Google Scholar 

  43. Smith ER, Scott RM. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus. 2008;24(2):E17.

    Article  PubMed  Google Scholar 

  44. Houkin K, Abe H, Yoshimoto T, Takahashi A. Is “unilateral” moyamoya disease different from moyamoya disease? J Neurosurg. 1996;85(5):772–6.

    Article  CAS  PubMed  Google Scholar 

  45. Hayashi K, Suyama K, Nagata I. Clinical features of unilateral moyamoya disease. Neurol Med Chir. 2010;50(5):378–85.

    Article  Google Scholar 

  46. Kawano T, Fukui M, Hashimoto N, Yonekawa Y. Follow-up study of patients with “unilateral” moyamoya disease. Neurol Med Chir. 1994;34(11):744–7.

    Article  CAS  Google Scholar 

  47. Park EK, Lee YH, Shim KW, Choi JU, Kim DS. Natural history and progression factors of unilateral moyamoya disease in pediatric patients. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery. 2011;27(8):1281–7.

    Article  Google Scholar 

  48. Yeon JY, Shin HJ, Kong DS, Seol HJ, Kim JS, Hong SC, et al. The prediction of contralateral progression in children and adolescents with unilateral moyamoya disease. Stroke. 2011;42(10):2973–6.

    Article  PubMed  Google Scholar 

  49. Kim JE, Pang CH. Diagnosis and treatment of adult Moyamoya disease. Journal of the Korean Medical Association/Taehan Uisa Hyophoe Chi. 2019;62(11):577–85.

    Article  Google Scholar 

  50. Kim JE, Kim KM, Kim JG, Kang HS, Bang JS, Son YJ, et al. Clinical features of adult moyamoya disease with special reference to the diagnosis. Neurol Med Chir. 2012;52(5):311–7.

    Article  Google Scholar 

  51. Nariai T, Suzuki R, Matsushima Y, Ichimura K, Hirakawa K, Ishii K, et al. Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia. Stroke. 1994;25(5):1014–21.

    Article  CAS  PubMed  Google Scholar 

  52. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery. 2005;21(5):358–64.

    Article  Google Scholar 

  53. Veeravagu A, Guzman R, Patil CG, Hou LC, Lee M, Steinberg GK. Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus. 2008;24(2):E16.

    Article  PubMed  Google Scholar 

  54. Zheng J, Yu LB, Dai KF, Zhang Y, Wang R, Zhang D. Clinical features, surgical treatment, and long-term outcome of a multicenter cohort of pediatric Moyamoya. Front Neurol. 2019;10:14.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K. Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 1992;31(3):401–5.

    Article  CAS  PubMed  Google Scholar 

  56. Zhao Y, Lu J, Yu S, Li J, Deng X, Zhang Y, et al. Comparison of long-term effect between direct and indirect bypass for pediatric ischemic-type Moyamoya disease: a propensity score-matched study. Front Neurol. 2019;10:795.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol. 2000;15(5):350–6.

    Article  CAS  PubMed  Google Scholar 

  58. Adelson PD, Scott RM. Pial synangiosis for moyamoya syndrome in children. Pediatr Neurosurg. 1995;23(1):26–33.

    Article  CAS  PubMed  Google Scholar 

  59. Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, et al. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovasc Dis (Basel, Switzerland). 2015;39(2):75–81.

    Article  Google Scholar 

  60. Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, et al. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg. 2014;121(2):432–40.

    Article  PubMed  Google Scholar 

  61. Heros RC, Scott RM, Kistler JP, Ackerman RH, Conner ES. Temporary neurological deterioration after extracranial-intracranial bypass. Neurosurgery. 1984;15(2):178–85.

    Article  CAS  PubMed  Google Scholar 

  62. Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr. 2010;6(1):73–81.

    Article  PubMed  Google Scholar 

  63. Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. Stroke. 2012;43(10):2610–6.

    Article  PubMed  Google Scholar 

  64. Fujimura M, Kaneta T, Tominaga T. Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery. 2008;24(7):827–32.

    Article  Google Scholar 

  65. Rashad S, Fujimura M, Niizuma K, Endo H, Tominaga T. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management. Neurosurg Rev. 2016;39(4):615–23.

    Article  PubMed  Google Scholar 

  66. Kim T, Oh CW, Kwon OK, Hwang G, Kim JE, Kang HS, et al. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg. 2016;124(6):1788–93.

    Article  PubMed  Google Scholar 

  67. Bang JS, Kwon OK, Kim JE, Kang HS, Park H, Cho SY, et al. Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease. Neurosurgery. 2012;70(3):625–32. discussion 32–3

    Article  PubMed  Google Scholar 

  68. Kuroda S, Houkin K, Ishikawa T, Nakayama N, Iwasaki Y. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery. 2010;66(6):1093–101. discussion 101

    Article  PubMed  Google Scholar 

  69. Bao XY, Zhang Y, Wang QN, Zhang Q, Wang H, Zhang ZS, et al. Long-term outcomes after Encephaloduroarteriosynangiosis in adult patients with Moyamoya disease presenting with ischemia. World Neurosurg. 2018;115:e482–e9.

    Article  PubMed  Google Scholar 

  70. Dusick JR, Gonzalez NR, Martin NA. Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery. 2011;68(1):34–43. discussion

    Article  PubMed  Google Scholar 

  71. Gross BA, Du R. The natural history of moyamoya in a north American adult cohort. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia. 2013;20(1):44–8.

    Article  Google Scholar 

  72. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, et al. Clinical features and outcome in north American adults with moyamoya phenomenon. Stroke. 2006;37(6):1490–6.

    Article  PubMed  Google Scholar 

  73. Takahashi JC, Funaki T, Houkin K, Kuroda S, Fujimura M, Tomata Y, et al. Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic moyamoya disease: a supplementary analysis of the Japan adult Moyamoya trial. J Neurosurg. 2020:1–6.

    Google Scholar 

  74. Ha EJ, Kim KH, Wang KC, Phi JH, Lee JY, Choi JW, et al. Long-term outcomes of indirect bypass for 629 children with Moyamoya disease: longitudinal and Cross-sectional analysis. Stroke. 2019;50(11):3177–83.

    Article  PubMed  Google Scholar 

  75. Kim DS, Huh PW, Kim HS, Kim IS, Choi S, Mok JH, et al. Surgical treatment of moyamoya disease in adults: combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir. 2012;52(5):333–8.

    Article  Google Scholar 

  76. Kim T, Bang JS, Kwon OK, Hwang G, Kim JE, Kang HS, et al. Hemodynamic changes after unilateral revascularization for Moyamoya disease: serial assessment by quantitative magnetic resonance angiography. Neurosurgery. 2017;81(1):111–9.

    Article  PubMed  Google Scholar 

  77. Kim KM, Kim JE, Cho WS, Kang HS, Son YJ, Han MH, et al. Natural history and risk factor of recurrent hemorrhage in hemorrhagic adult Moyamoya disease. Neurosurgery. 2017;81(2):289–96.

    Article  PubMed  Google Scholar 

  78. Choi WS, Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, et al. Thirteen-year experience of 44 patients with adult hemorrhagic Moyamoya disease from a single institution: clinical analysis by management modality. Journal of cerebrovascular and endovascular neurosurgery. 2013;15(3):191–9.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Ahn JH, Wang KC, Phi JH, Lee JY, Cho BK, Kim IO, et al. Hemorrhagic moyamoya disease in children: clinical features and surgical outcome. Child’s Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery. 2012;28(2):237–45.

    Article  Google Scholar 

  80. Phi JH, Wang KC, Cho BK, Lee MS, Lee JH, Yu KS, et al. Long-term social outcome in children with moyamoya disease who have reached adulthood. J Neurosurg Pediatr. 2011;8(3):303–9.

    Article  PubMed  Google Scholar 

  81. Lee JY, Phi JH, Wang KC, Cho BK, Shin MS, Kim SK. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention. Cerebrovasc Dis (Basel, Switzerland). 2011;31(3):230–7.

    Article  Google Scholar 

  82. Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg. 2018;128(3):793–9.

    Article  PubMed  Google Scholar 

  83. Choi IJ, Cho SJ, Chang JC, Park SQ, Park HK. Angiographic results of indirect and combined bypass surgery for adult moyamoya disease. J Cerebrovasc Endovasc Neurosurg. 2012;14(3):216–22.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir. 2012;154(7):1179–87.

    Article  PubMed  Google Scholar 

  85. Jo KI, Kim MS, Yeon JY, Kim JS, Hong SC. Recurrent bleeding in hemorrhagic Moyamoya disease : prognostic implications of the perfusion status. J Korean Neurosurg Soc. 2016;59(2):117–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgement

The authors appreciate Dr. Jin Woo Bae, Si Un Lee, and Tackeun Kim for helping with the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Seoul National University College of Medicine, Seoul, South Korea

    Jeong Eun Kim & Chang Wan Oh

  2. Seoul National University Hospital, Seoul, South Korea

    Jeong Eun Kim

  3. Seoul National University Bundang Hospital, Seongnam-si, South Korea

    Chang Wan Oh

Authors
  1. Jeong Eun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chang Wan Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chang Wan Oh .

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan

    Satoshi Kuroda

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kim, J.E., Oh, C.W. (2021). Long-Term Outcome of Revascularization Surgery for Moyamoya Disease in Korea. In: Kuroda, S. (eds) Moyamoya Disease: Current Knowledge and Future Perspectives. Springer, Singapore. https://doi.org/10.1007/978-981-33-6404-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-981-33-6404-2_23

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-33-6403-5

  • Online ISBN: 978-981-33-6404-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation